Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study | The BMJ

Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study | The BMJ

Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study

BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k3225 (Published 29 August 2018)Cite this as: BMJ 2018;362:k3225

• Article
• Related content
• Metrics
• Responses
• Peer review

1. Katerina Trajanoska, PhD student1 2,
2. John A Morris, PhD student3 4,
3. Ling Oei, assistant professor1 2,
4. Hou-Feng Zheng, professor5 6,
5. David M Evans, professor7 8,
6. Douglas P Kiel, professor9 10,
7. Claes Ohlsson, professor11,
8. J Brent Richards, professor3 4,
9. Fernando Rivadeneira, associate professor1 2
10. on behalf of the GEFOS/GENOMOS consortium and the 23andMe research team

Author affiliations

1. Correspondence to: F Rivadeneira f.rivadeneira@erasmusmc.nl, and J B Richards brent.richards@mcgill.ca

• Accepted 2 July 2018